Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
abort, abroad, absolute, absorption, admitted, advent, Africa, aggressively, alliance, amino, analog, analytical, antagonist, antidilutive, antiretroviral, antiviral, apparent, arbitration, arose, ArQule, attrition, augment, avoid, back, Background, bar, Beckman, BKL, blocking, blood, Bristol, broadly, buy, carefully, cartilage, catalyze, cessation, cGMP, challenged, challenging, chemical, China, chronic, circumvented, claimant, classic, Clay, clearance, cleavage, cleaved, closure, cohort, Colorado, colorectal, commonly, competitor, compliant, compulsory, conceived, Conference, constantly, contrast, cornerstone, counterclaim, credentialed, CRO, cytotoxic, david, default, degrade, deschutter, destruction, disagree, dissatisfied, distinguish, divided, dividing, dose, dosing, drawn, EC, EGF, EGFR, Elan, embedded, Emory, encompassing, enroll, enrollment, entail, epidermal, escrow, exceeded, excretion, exploit, fit, formal, formulation, franchise, Genzyme, Gilead, GlaxoSmithKline, Gleevec, goal, greatest, greatly, guide, healthcare, healthy, Henry, hereto, HIV, immune, immunodeficiency, incidence, inconclusive, indefinitely, induce, ineffective, infected, infection, inflow, inhibitor, injured, instance, interfering, invalid, invalidated, invalidating, investee, IPRD, Iressa, IV, Keller, kinase, Korea, lifted, likelihood, load, markedly, maximize, Medicaid, Medicare, Mexico, Microbiology, Middle, migration, morbidity, mortality, Murphy, neuropathic, niche, Nonemployee, Nonmonetary, nonperformance, notice, NRTI, nucleoside, occupancy, oncology, Opportunistic, opposed, outlined, oversight, pain, parallel, pari, passu, Patricia, peptide, perpetuating, pertaining, Pharmasset, physician, placebo, pledge, pocket, potent, premium, prescription, proinflammatory, protease, protocol, proven, provoke, proximity, pursuit, raw, recall, recalled, reform, reformulation, reimbursement, rejection, relinquishing, remanded, replication, reply, repudiated, resistance, resistant, retention, Reverset, Road, robust, Route, scavenge, scavenger, Schreck, scrapped, seizure, Senomyx, Sepracor, sequential, sheddase, show, shutdown, signaling, Similarly, smaller, soluble, stand, Station, stay, strictly, strongly, succeeded, surveillance, suspend, Sweden, syndrome, synthesizing, tenant, TGFalpha, tolerance, tolerated, tumor, tyrosine, unacceptable, undelivered, undergone, underway, undesirable, unmet, unoccupied, unsuitable, vacancy, Vermont, VIE, Villanova, viral, waiver, white, wide, widely, Wilmington, withdrawn, withFASB, workplace
Removed:
abandon, accessed, affiliate, alleviate, Amersham, analyze, analyzing, antisense, architecture, attached, attaining, automated, aware, behavior, Biochemistry, biopharmaceutical, Biotech, body, breached, browse, CA, capable, catastrophe, cease, characterization, characterize, characterized, Chiron, claimed, classification, Client, cloning, College, collinson, commerce, commercialized, comparing, comparison, comprising, computerized, computing, conflict, consecutive, consulting, content, controversy, Cooper, cooperation, CooperVision, corrupt, corruption, cryptography, cum, cure, cycle, derivation, designating, detect, deter, diagnosed, disaster, discovered, discovering, diseased, dividend, document, earthquake, easier, educate, effected, efficiency, electronic, emerged, enact, enacted, encountered, examined, expiration, expressed, expressly, extraordinary, fabrication, fall, favor, finite, firm, flagship, Forecasting, formation, fragmented, Francisco, freely, French, function, GenBank, GeneLogic, genome, genotyping, govern, Graham, guidance, heightened, henn, hormone, identifying, implement, improve, inadequate, inappropriate, inferred, intent, intention, interface, internet, interpret, invent, inventorship, isolated, jeffrey, Kalamazoo, largest, laude, locate, Logic, lost, lot, magna, maximum, MEN, microbial, Millennium, mining, misappropriated, modification, mouse, moving, narrowly, negotiation, network, occurring, online, operation, optimizing, partial, pathology, pathway, PCT, Pharmacia, plant, policing, Political, Porter, positional, predicted, profitable, progression, prolonged, proportion, Publication, purified, Radio, rat, realize, recruiting, region, regulate, regulating, reliability, renew, renewed, restrictive, retroactively, return, robotic, sample, scheduled, Science, Secretary, seismically, separation, sequence, SGI, shortest, silico, simultaneously, size, slower, speak, split, stimulate, strain, strung, subscribe, subscriber, supplied, supported, surface, talented, thereof, timothy, tool, tradable, tradename, transmission, treating, Treaty, typical, uncover, understand, understanding, unfavorable, unique, unpatentable, uploaded, variation, violated
Filing tables
Filing exhibits
- 10-K Annual report
- 10.46 Offer of Employment Letter Dated September 2, 2003 to David C. Hastings
- 10.47 Offer of Employment Letter Dated September 2, 2003 to John A. Keller
- 10.48 Form of Employment Agreement Effective November 21, 2003
- 10.49 Retention Agreement Effective As of November 21, 2003
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Ernst & Young LLP, Independent Auditors
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
INCY similar filings
Filing view
External links
Exhibit 32.1
STATEMENT PURSUANT TO
18 U.S.C. SECTION 1350
With reference to the Annual Report of Incyte Corporation (the “Company”) on Form 10-K for the year ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul A. Friedman, Chief Executive Officer of the Company, certify, for the purposes of 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ PAUL A. FRIEDMAN |
Paul A. Friedman Chief Executive Officer March 15, 2004 |